Altimmune to Participate in the Leerink Global Healthcare Conference
03 3월 2025 - 9:30PM
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage
biopharmaceutical company, today announced that members of the
Company’s management team will participate in a fireside chat at
the Leerink Global Healthcare Conference. Details are as follows:
|
Conference: |
Leerink Global
Healthcare Conference |
|
|
|
|
Date/Time: |
Monday, March 10, 2025, at 3:40 p.m. EST |
The session will be webcast and can be accessed
by visiting the Events section of the Altimmune website.
About Altimmune
Altimmune is a late clinical-stage
biopharmaceutical company focused on developing innovative
next-generation peptide-based therapeutics. The Company is
developing pemvidutide, a GLP-1/glucagon dual receptor agonist for
the treatment of obesity and MASH. For more information, please
visit www.altimmune.com.
Follow @Altimmune, Inc. on
LinkedInFollow @AltimmuneInc on
Twitter
Company Contact:Greg WeaverChief Financial
OfficerPhone: 240-654-1450ir@altimmune.com
Investor Contact:Lee RothBurns McClellanPhone:
646-382-3403lroth@burnsmc.com
Media Contact:Danielle CanteyInizio Evoke,
BiotechPhone: 619-826-4657Danielle.cantey@inizioevoke.com
This press release was published by a CLEAR® Verified
individual.
Altimmune (NASDAQ:ALT)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Altimmune (NASDAQ:ALT)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
